カテゴリー： LP Information, 世界, 部品/材料

世界のルマカトルAPI市場予測 2023年-2029年

◆英語タイトル：Global Lumacaftor API Market Growth 2023-2029
	◆商品コード：LP23JU7387 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：98 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥549,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥823,500	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,098,000	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のルマカトルAPI市場」は、過去の販売実績から2022年の世界のルマカトルAPIの総販売量を検討し、2023年から2029年の予測されるルマカトルAPIの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のルマカトルAPIの市場規模を掲載し、XXX百万米ドル規模の世界のルマカトルAPI市場の詳細な分析を提供します。本インサイトレポートは、世界のルマカトルAPI業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のルマカトルAPI市場における各社の独自のポジションをより深く理解するために、ルマカトルAPI製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のルマカトルAPI市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ルマカトルAPIの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ルマカトルAPIの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ルマカトルAPIのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ルマカトルAPIの世界主要メーカーとしては、VulcanChem、 Tecoland、 FCDA、 Viruj Pharma、 Pharmaffiliates、 Taizhou Crene Biotechnology、 Shanghaizehan biopharma technology、 Shijiazhuang Dingmin Pharmaceutical Sciences、 AlchemyPharmなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のルマカトルAPI市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではルマカトルAPI市場をセグメンテーションし、種類別 (純度98%以下、純度98%～99%、純度99%以上)、用途別 (研究、製薬)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度98%以下、純度98%～99%、純度99%以上

・用途別区分：研究、製薬

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のルマカトルAPI市場の10年間の市場状況・展望は？
・世界および地域別に見たルマカトルAPI市場成長の要因は何か？
・ルマカトルAPIの市場機会はエンドマーケットの規模によってどのように変化するのか？
・ルマカトルAPIのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ルマカトルAPIの年間販売量2018-2029、地域別現状・将来分析
・ルマカトルAPIの種類別セグメント：純度98%以下、純度98%～99%、純度99%以上
・ルマカトルAPIの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ルマカトルAPIの用途別セグメント：研究、製薬
・ルマカトルAPIの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のルマカトルAPI市場
・企業別のグローバルルマカトルAPI市場データ：2018-2023年の年間販売量、市場シェア
・企業別のルマカトルAPIの年間売上：2018-2023年の売上、市場シェア
・企業別のルマカトルAPI販売価格
・主要企業のルマカトルAPI生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ルマカトルAPIの地域別レビュー
・地域別のルマカトルAPI市場規模2018-2023：年間販売量、売上
・主要国別のルマカトルAPI市場規模2018-2023：年間販売量、売上
・南北アメリカのルマカトルAPI販売の成長
・アジア太平洋のルマカトルAPI販売の成長
・ヨーロッパのルマカトルAPI販売の成長
・中東・アフリカのルマカトルAPI販売の成長

南北アメリカ市場
・南北アメリカの国別のルマカトルAPI販売量、売上（2018-2023）
・南北アメリカのルマカトルAPIの種類別販売量
・南北アメリカのルマカトルAPIの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のルマカトルAPI販売量、売上（2018-2023）
・アジア太平洋のルマカトルAPIの種類別販売量
・アジア太平洋のルマカトルAPIの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のルマカトルAPI販売量、売上（2018-2023）
・ヨーロッパのルマカトルAPIの種類別販売量
・ヨーロッパのルマカトルAPIの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のルマカトルAPI販売量、売上（2018-2023）
・中東・アフリカのルマカトルAPIの種類別販売量
・中東・アフリカのルマカトルAPIの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ルマカトルAPIの製造コスト構造分析
・ルマカトルAPIの製造プロセス分析
・ルマカトルAPIの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ルマカトルAPIの主要なグローバル販売業者
・ルマカトルAPIの主要なグローバル顧客

地域別のルマカトルAPI市場予測レビュー
・地域別のルマカトルAPI市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ルマカトルAPIの種類別市場規模予測
・ルマカトルAPIの用途別市場規模予測

主要企業分析
VulcanChem、 Tecoland、 FCDA、 Viruj Pharma、 Pharmaffiliates、 Taizhou Crene Biotechnology、 Shanghaizehan biopharma technology、 Shijiazhuang Dingmin Pharmaceutical Sciences、 AlchemyPharm
・企業情報
・ルマカトルAPI製品
・ルマカトルAPI販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Lumacaftor is a pharmaceutical drug that acts as a chaperone during protein folding and increases the number of CFTR proteins that are trafficked to the cell surface.
LPI (LP Information)’ newest research report, the “Lumacaftor API Industry Forecast” looks at past sales and reviews total world Lumacaftor API sales in 2022, providing a comprehensive analysis by region and market sector of projected Lumacaftor API sales for 2023 through 2029. With Lumacaftor API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lumacaftor API industry.
This Insight Report provides a comprehensive analysis of the global Lumacaftor API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lumacaftor API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lumacaftor API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lumacaftor API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lumacaftor API.
The global Lumacaftor API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Lumacaftor API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Lumacaftor API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Lumacaftor API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Lumacaftor API players cover VulcanChem, Tecoland, FCDA, Viruj Pharma, Pharmaffiliates, Taizhou Crene Biotechnology, Shanghaizehan biopharma technology, Shijiazhuang Dingmin Pharmaceutical Sciences and AlchemyPharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Lumacaftor API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segmentation by application
Research
Pharmaceutical
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
VulcanChem
Tecoland
FCDA
Viruj Pharma
Pharmaffiliates
Taizhou Crene Biotechnology
Shanghaizehan biopharma technology
Shijiazhuang Dingmin Pharmaceutical Sciences
AlchemyPharm
Key Questions Addressed in this Report
What is the 10-year outlook for the global Lumacaftor API market?
What factors are driving Lumacaftor API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lumacaftor API market opportunities vary by end market size?
How does Lumacaftor API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lumacaftor API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Lumacaftor API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Lumacaftor API by Country/Region, 2018, 2022 & 2029
2.2 Lumacaftor API Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Lumacaftor API Sales by Type
2.3.1 Global Lumacaftor API Sales Market Share by Type (2018-2023)
2.3.2 Global Lumacaftor API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Lumacaftor API Sale Price by Type (2018-2023)
2.4 Lumacaftor API Segment by Application
2.4.1 Research
2.4.2 Pharmaceutical
2.5 Lumacaftor API Sales by Application
2.5.1 Global Lumacaftor API Sale Market Share by Application (2018-2023)
2.5.2 Global Lumacaftor API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Lumacaftor API Sale Price by Application (2018-2023)
3 Global Lumacaftor API by Company
3.1 Global Lumacaftor API Breakdown Data by Company
3.1.1 Global Lumacaftor API Annual Sales by Company (2018-2023)
3.1.2 Global Lumacaftor API Sales Market Share by Company (2018-2023)
3.2 Global Lumacaftor API Annual Revenue by Company (2018-2023)
3.2.1 Global Lumacaftor API Revenue by Company (2018-2023)
3.2.2 Global Lumacaftor API Revenue Market Share by Company (2018-2023)
3.3 Global Lumacaftor API Sale Price by Company
3.4 Key Manufacturers Lumacaftor API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lumacaftor API Product Location Distribution
3.4.2 Players Lumacaftor API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lumacaftor API by Geographic Region
4.1 World Historic Lumacaftor API Market Size by Geographic Region (2018-2023)
4.1.1 Global Lumacaftor API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Lumacaftor API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Lumacaftor API Market Size by Country/Region (2018-2023)
4.2.1 Global Lumacaftor API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Lumacaftor API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Lumacaftor API Sales Growth
4.4 APAC Lumacaftor API Sales Growth
4.5 Europe Lumacaftor API Sales Growth
4.6 Middle East & Africa Lumacaftor API Sales Growth
5 Americas
5.1 Americas Lumacaftor API Sales by Country
5.1.1 Americas Lumacaftor API Sales by Country (2018-2023)
5.1.2 Americas Lumacaftor API Revenue by Country (2018-2023)
5.2 Americas Lumacaftor API Sales by Type
5.3 Americas Lumacaftor API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lumacaftor API Sales by Region
6.1.1 APAC Lumacaftor API Sales by Region (2018-2023)
6.1.2 APAC Lumacaftor API Revenue by Region (2018-2023)
6.2 APAC Lumacaftor API Sales by Type
6.3 APAC Lumacaftor API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lumacaftor API by Country
7.1.1 Europe Lumacaftor API Sales by Country (2018-2023)
7.1.2 Europe Lumacaftor API Revenue by Country (2018-2023)
7.2 Europe Lumacaftor API Sales by Type
7.3 Europe Lumacaftor API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lumacaftor API by Country
8.1.1 Middle East & Africa Lumacaftor API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Lumacaftor API Revenue by Country (2018-2023)
8.2 Middle East & Africa Lumacaftor API Sales by Type
8.3 Middle East & Africa Lumacaftor API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lumacaftor API
10.3 Manufacturing Process Analysis of Lumacaftor API
10.4 Industry Chain Structure of Lumacaftor API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lumacaftor API Distributors
11.3 Lumacaftor API Customer
12 World Forecast Review for Lumacaftor API by Geographic Region
12.1 Global Lumacaftor API Market Size Forecast by Region
12.1.1 Global Lumacaftor API Forecast by Region (2024-2029)
12.1.2 Global Lumacaftor API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lumacaftor API Forecast by Type
12.7 Global Lumacaftor API Forecast by Application
13 Key Players Analysis
13.1 VulcanChem
13.1.1 VulcanChem Company Information
13.1.2 VulcanChem Lumacaftor API Product Portfolios and Specifications
13.1.3 VulcanChem Lumacaftor API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 VulcanChem Main Business Overview
13.1.5 VulcanChem Latest Developments
13.2 Tecoland
13.2.1 Tecoland Company Information
13.2.2 Tecoland Lumacaftor API Product Portfolios and Specifications
13.2.3 Tecoland Lumacaftor API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Tecoland Main Business Overview
13.2.5 Tecoland Latest Developments
13.3 FCDA
13.3.1 FCDA Company Information
13.3.2 FCDA Lumacaftor API Product Portfolios and Specifications
13.3.3 FCDA Lumacaftor API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 FCDA Main Business Overview
13.3.5 FCDA Latest Developments
13.4 Viruj Pharma
13.4.1 Viruj Pharma Company Information
13.4.2 Viruj Pharma Lumacaftor API Product Portfolios and Specifications
13.4.3 Viruj Pharma Lumacaftor API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Viruj Pharma Main Business Overview
13.4.5 Viruj Pharma Latest Developments
13.5 Pharmaffiliates
13.5.1 Pharmaffiliates Company Information
13.5.2 Pharmaffiliates Lumacaftor API Product Portfolios and Specifications
13.5.3 Pharmaffiliates Lumacaftor API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Pharmaffiliates Main Business Overview
13.5.5 Pharmaffiliates Latest Developments
13.6 Taizhou Crene Biotechnology
13.6.1 Taizhou Crene Biotechnology Company Information
13.6.2 Taizhou Crene Biotechnology Lumacaftor API Product Portfolios and Specifications
13.6.3 Taizhou Crene Biotechnology Lumacaftor API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Taizhou Crene Biotechnology Main Business Overview
13.6.5 Taizhou Crene Biotechnology Latest Developments
13.7 Shanghaizehan biopharma technology
13.7.1 Shanghaizehan biopharma technology Company Information
13.7.2 Shanghaizehan biopharma technology Lumacaftor API Product Portfolios and Specifications
13.7.3 Shanghaizehan biopharma technology Lumacaftor API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shanghaizehan biopharma technology Main Business Overview
13.7.5 Shanghaizehan biopharma technology Latest Developments
13.8 Shijiazhuang Dingmin Pharmaceutical Sciences
13.8.1 Shijiazhuang Dingmin Pharmaceutical Sciences Company Information
13.8.2 Shijiazhuang Dingmin Pharmaceutical Sciences Lumacaftor API Product Portfolios and Specifications
13.8.3 Shijiazhuang Dingmin Pharmaceutical Sciences Lumacaftor API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Shijiazhuang Dingmin Pharmaceutical Sciences Main Business Overview
13.8.5 Shijiazhuang Dingmin Pharmaceutical Sciences Latest Developments
13.9 AlchemyPharm
13.9.1 AlchemyPharm Company Information
13.9.2 AlchemyPharm Lumacaftor API Product Portfolios and Specifications
13.9.3 AlchemyPharm Lumacaftor API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 AlchemyPharm Main Business Overview
13.9.5 AlchemyPharm Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Lumacaftor API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Lumacaftor API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Min Purity Less Than 98%
Table 4. Major Players of Min Purity 98%-99%
Table 5. Major Players of Min Purity More Than 99%
Table 6. Global Lumacaftor API Sales by Type (2018-2023) & (MT)
Table 7. Global Lumacaftor API Sales Market Share by Type (2018-2023)
Table 8. Global Lumacaftor API Revenue by Type (2018-2023) & ($ million)
Table 9. Global Lumacaftor API Revenue Market Share by Type (2018-2023)
Table 10. Global Lumacaftor API Sale Price by Type (2018-2023) & (USD/MT)
Table 11. Global Lumacaftor API Sales by Application (2018-2023) & (MT)
Table 12. Global Lumacaftor API Sales Market Share by Application (2018-2023)
Table 13. Global Lumacaftor API Revenue by Application (2018-2023)
Table 14. Global Lumacaftor API Revenue Market Share by Application (2018-2023)
Table 15. Global Lumacaftor API Sale Price by Application (2018-2023) & (USD/MT)
Table 16. Global Lumacaftor API Sales by Company (2018-2023) & (MT)
Table 17. Global Lumacaftor API Sales Market Share by Company (2018-2023)
Table 18. Global Lumacaftor API Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Lumacaftor API Revenue Market Share by Company (2018-2023)
Table 20. Global Lumacaftor API Sale Price by Company (2018-2023) & (USD/MT)
Table 21. Key Manufacturers Lumacaftor API Producing Area Distribution and Sales Area
Table 22. Players Lumacaftor API Products Offered
Table 23. Lumacaftor API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Lumacaftor API Sales by Geographic Region (2018-2023) & (MT)
Table 27. Global Lumacaftor API Sales Market Share Geographic Region (2018-2023)
Table 28. Global Lumacaftor API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Lumacaftor API Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Lumacaftor API Sales by Country/Region (2018-2023) & (MT)
Table 31. Global Lumacaftor API Sales Market Share by Country/Region (2018-2023)
Table 32. Global Lumacaftor API Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Lumacaftor API Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Lumacaftor API Sales by Country (2018-2023) & (MT)
Table 35. Americas Lumacaftor API Sales Market Share by Country (2018-2023)
Table 36. Americas Lumacaftor API Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Lumacaftor API Revenue Market Share by Country (2018-2023)
Table 38. Americas Lumacaftor API Sales by Type (2018-2023) & (MT)
Table 39. Americas Lumacaftor API Sales by Application (2018-2023) & (MT)
Table 40. APAC Lumacaftor API Sales by Region (2018-2023) & (MT)
Table 41. APAC Lumacaftor API Sales Market Share by Region (2018-2023)
Table 42. APAC Lumacaftor API Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Lumacaftor API Revenue Market Share by Region (2018-2023)
Table 44. APAC Lumacaftor API Sales by Type (2018-2023) & (MT)
Table 45. APAC Lumacaftor API Sales by Application (2018-2023) & (MT)
Table 46. Europe Lumacaftor API Sales by Country (2018-2023) & (MT)
Table 47. Europe Lumacaftor API Sales Market Share by Country (2018-2023)
Table 48. Europe Lumacaftor API Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Lumacaftor API Revenue Market Share by Country (2018-2023)
Table 50. Europe Lumacaftor API Sales by Type (2018-2023) & (MT)
Table 51. Europe Lumacaftor API Sales by Application (2018-2023) & (MT)
Table 52. Middle East & Africa Lumacaftor API Sales by Country (2018-2023) & (MT)
Table 53. Middle East & Africa Lumacaftor API Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Lumacaftor API Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Lumacaftor API Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Lumacaftor API Sales by Type (2018-2023) & (MT)
Table 57. Middle East & Africa Lumacaftor API Sales by Application (2018-2023) & (MT)
Table 58. Key Market Drivers & Growth Opportunities of Lumacaftor API
Table 59. Key Market Challenges & Risks of Lumacaftor API
Table 60. Key Industry Trends of Lumacaftor API
Table 61. Lumacaftor API Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Lumacaftor API Distributors List
Table 64. Lumacaftor API Customer List
Table 65. Global Lumacaftor API Sales Forecast by Region (2024-2029) & (MT)
Table 66. Global Lumacaftor API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Lumacaftor API Sales Forecast by Country (2024-2029) & (MT)
Table 68. Americas Lumacaftor API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Lumacaftor API Sales Forecast by Region (2024-2029) & (MT)
Table 70. APAC Lumacaftor API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Lumacaftor API Sales Forecast by Country (2024-2029) & (MT)
Table 72. Europe Lumacaftor API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Lumacaftor API Sales Forecast by Country (2024-2029) & (MT)
Table 74. Middle East & Africa Lumacaftor API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Lumacaftor API Sales Forecast by Type (2024-2029) & (MT)
Table 76. Global Lumacaftor API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Lumacaftor API Sales Forecast by Application (2024-2029) & (MT)
Table 78. Global Lumacaftor API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. VulcanChem Basic Information, Lumacaftor API Manufacturing Base, Sales Area and Its Competitors
Table 80. VulcanChem Lumacaftor API Product Portfolios and Specifications
Table 81. VulcanChem Lumacaftor API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. VulcanChem Main Business
Table 83. VulcanChem Latest Developments
Table 84. Tecoland Basic Information, Lumacaftor API Manufacturing Base, Sales Area and Its Competitors
Table 85. Tecoland Lumacaftor API Product Portfolios and Specifications
Table 86. Tecoland Lumacaftor API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Tecoland Main Business
Table 88. Tecoland Latest Developments
Table 89. FCDA Basic Information, Lumacaftor API Manufacturing Base, Sales Area and Its Competitors
Table 90. FCDA Lumacaftor API Product Portfolios and Specifications
Table 91. FCDA Lumacaftor API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. FCDA Main Business
Table 93. FCDA Latest Developments
Table 94. Viruj Pharma Basic Information, Lumacaftor API Manufacturing Base, Sales Area and Its Competitors
Table 95. Viruj Pharma Lumacaftor API Product Portfolios and Specifications
Table 96. Viruj Pharma Lumacaftor API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Viruj Pharma Main Business
Table 98. Viruj Pharma Latest Developments
Table 99. Pharmaffiliates Basic Information, Lumacaftor API Manufacturing Base, Sales Area and Its Competitors
Table 100. Pharmaffiliates Lumacaftor API Product Portfolios and Specifications
Table 101. Pharmaffiliates Lumacaftor API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Pharmaffiliates Main Business
Table 103. Pharmaffiliates Latest Developments
Table 104. Taizhou Crene Biotechnology Basic Information, Lumacaftor API Manufacturing Base, Sales Area and Its Competitors
Table 105. Taizhou Crene Biotechnology Lumacaftor API Product Portfolios and Specifications
Table 106. Taizhou Crene Biotechnology Lumacaftor API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Taizhou Crene Biotechnology Main Business
Table 108. Taizhou Crene Biotechnology Latest Developments
Table 109. Shanghaizehan biopharma technology Basic Information, Lumacaftor API Manufacturing Base, Sales Area and Its Competitors
Table 110. Shanghaizehan biopharma technology Lumacaftor API Product Portfolios and Specifications
Table 111. Shanghaizehan biopharma technology Lumacaftor API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. Shanghaizehan biopharma technology Main Business
Table 113. Shanghaizehan biopharma technology Latest Developments
Table 114. Shijiazhuang Dingmin Pharmaceutical Sciences Basic Information, Lumacaftor API Manufacturing Base, Sales Area and Its Competitors
Table 115. Shijiazhuang Dingmin Pharmaceutical Sciences Lumacaftor API Product Portfolios and Specifications
Table 116. Shijiazhuang Dingmin Pharmaceutical Sciences Lumacaftor API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Shijiazhuang Dingmin Pharmaceutical Sciences Main Business
Table 118. Shijiazhuang Dingmin Pharmaceutical Sciences Latest Developments
Table 119. AlchemyPharm Basic Information, Lumacaftor API Manufacturing Base, Sales Area and Its Competitors
Table 120. AlchemyPharm Lumacaftor API Product Portfolios and Specifications
Table 121. AlchemyPharm Lumacaftor API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. AlchemyPharm Main Business
Table 123. AlchemyPharm Latest Developments
List of Figures
Figure 1. Picture of Lumacaftor API
Figure 2. Lumacaftor API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lumacaftor API Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Lumacaftor API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Lumacaftor API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Min Purity Less Than 98%
Figure 10. Product Picture of Min Purity 98%-99%
Figure 11. Product Picture of Min Purity More Than 99%
Figure 12. Global Lumacaftor API Sales Market Share by Type in 2022
Figure 13. Global Lumacaftor API Revenue Market Share by Type (2018-2023)
Figure 14. Lumacaftor API Consumed in Research
Figure 15. Global Lumacaftor API Market: Research (2018-2023) & (MT)
Figure 16. Lumacaftor API Consumed in Pharmaceutical
Figure 17. Global Lumacaftor API Market: Pharmaceutical (2018-2023) & (MT)
Figure 18. Global Lumacaftor API Sales Market Share by Application (2022)
Figure 19. Global Lumacaftor API Revenue Market Share by Application in 2022
Figure 20. Lumacaftor API Sales Market by Company in 2022 (MT)
Figure 21. Global Lumacaftor API Sales Market Share by Company in 2022
Figure 22. Lumacaftor API Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Lumacaftor API Revenue Market Share by Company in 2022
Figure 24. Global Lumacaftor API Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Lumacaftor API Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Lumacaftor API Sales 2018-2023 (MT)
Figure 27. Americas Lumacaftor API Revenue 2018-2023 ($ Millions)
Figure 28. APAC Lumacaftor API Sales 2018-2023 (MT)
Figure 29. APAC Lumacaftor API Revenue 2018-2023 ($ Millions)
Figure 30. Europe Lumacaftor API Sales 2018-2023 (MT)
Figure 31. Europe Lumacaftor API Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Lumacaftor API Sales 2018-2023 (MT)
Figure 33. Middle East & Africa Lumacaftor API Revenue 2018-2023 ($ Millions)
Figure 34. Americas Lumacaftor API Sales Market Share by Country in 2022
Figure 35. Americas Lumacaftor API Revenue Market Share by Country in 2022
Figure 36. Americas Lumacaftor API Sales Market Share by Type (2018-2023)
Figure 37. Americas Lumacaftor API Sales Market Share by Application (2018-2023)
Figure 38. United States Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Lumacaftor API Sales Market Share by Region in 2022
Figure 43. APAC Lumacaftor API Revenue Market Share by Regions in 2022
Figure 44. APAC Lumacaftor API Sales Market Share by Type (2018-2023)
Figure 45. APAC Lumacaftor API Sales Market Share by Application (2018-2023)
Figure 46. China Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Lumacaftor API Sales Market Share by Country in 2022
Figure 54. Europe Lumacaftor API Revenue Market Share by Country in 2022
Figure 55. Europe Lumacaftor API Sales Market Share by Type (2018-2023)
Figure 56. Europe Lumacaftor API Sales Market Share by Application (2018-2023)
Figure 57. Germany Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Lumacaftor API Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Lumacaftor API Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Lumacaftor API Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Lumacaftor API Sales Market Share by Application (2018-2023)
Figure 66. Egypt Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Lumacaftor API Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Lumacaftor API in 2022
Figure 72. Manufacturing Process Analysis of Lumacaftor API
Figure 73. Industry Chain Structure of Lumacaftor API
Figure 74. Channels of Distribution
Figure 75. Global Lumacaftor API Sales Market Forecast by Region (2024-2029)
Figure 76. Global Lumacaftor API Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Lumacaftor API Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Lumacaftor API Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Lumacaftor API Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Lumacaftor API Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のルマカトルAPI市場予測 2023年-2029年(Global Lumacaftor API Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のルマカトルAPI市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp